Capundag, Samuel M.

HRN: 29-33-79  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/21/2026
07/30/2026
IV
300
Q6h
Sepsis Sec To Infected Fistula-in-ano Vs Perianal Abscess
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: